Jeff Livingston, senior solutions consultant with QAD DynaSys, explains the importance of resilience in the supply-chain function, in times of high demand variability and uncertainty.
Robert Eubanks, director of healthcare and life sciences with West Monroe, discuses the changes in how vaccines and drug therapies are developed and distributed as a result of the COVID-19 pandemic.
Yossi Sheffi, Elisha Gray II Professor of Engineering Systems & Director of the MIT Center for Transportation and Logistics, discusses his new book, The New (Ab)Normal: Reshaping Business and Supply Chain Strategy Beyond Covid-19.
Phil Renaud, executive director of The Risk Institute at The Ohio State University’s Fisher College of Business, runs down the level of risk to supply chains created by relationships with third parties — and relates how a certain type of third party can help to mitigate it.